Lucid Diagnostics (LUCD)
(Real Time Quote from BATS)
$0.81 USD
-0.01 (-0.94%)
Updated Oct 2, 2024 12:16 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Industry / Sector Report
Industry : Medical - Instruments
Zacks Industry Rank
Top 20% (50 out of 252)Zacks Sector Rank
Top 13% (2 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.33 | 1.65 | 9.99 |
Current Quarter Estimate | -0.16 | 4.85 | 63.00 |
Year Ago Quarter Estimate | -0.24 | 3.54 | 52.25 |
Next Quarter Estimate | -0.16 | 5.70 | 66.00 |
Next Year Estimate | -0.54 | 24.65 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 2.17 | 13.60 | 15.67 |
Next Year | 40.00 | 20.50 | 11.34 |
Last 5 Years | NA | 10.20 | 8.10 |
Next 5 Years | NA | 13.30 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | 8.37 |
Price/Book (MRQ) | NA | 2.36 |
Price/Cash Flow (MRFY) | NA | 19.29 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -1,227.74% | -27.47% |
Return on Equity (TTM) | NA | -24.27% |
Debt to Equity (MRQ) | NA | 9.17 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.